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Relationship between Chronic Disease
Conditions and Colorectal Cancer Screening:
Results from the 2012 National Health
Interview Survey Data
Daniel Owusu, Joshua Longcoy, Megan Quinn, Ke-Sheng Wang*
Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee
State University, Johnson City, TN 37614, USA
Abstract
Background: Uptake of screening remains crucial in the prevention of both the incidence of colorectal cancer (CRC) and its
mortality.
Objectives: To estimate the prevalence of CRC screening and identify chronic conditions that predict CRC screening uptake
among US adults using the 2012 National Health Interview Survey (NHIS) data.
Materials and Methods: A cross-sectional analysis of the 2012 NHIS data. Chronic conditions examined were hypertension,
cancer history, arthritis, ulcer, and high cholesterol level. A total of 21,511 participants were included in the analysis. Weighted
univariate and multiple logistic regression analyses in SAS ver. 9.2 were used to estimate the odds ratios (ORs) with 95%
confidence intervals (CIs).
Results: The overall prevalence of CRC screening was 19%. The prevalence of CRC screening in adults with cancer history,
hypertension, ulcer, high cholesterol, and arthritis was significantly higher than those without the chronic conditions (26%
vs.18%, 23% vs.16%, 25% vs.18%, 23% vs. 16%, and 23% vs. 17%, respectively). After adjusting for potential factors,
hypertension (OR=1.18, 95%CI=1.08-1.30), ulcer (OR=1.28, 95%CI=1.10-1.48), high cholesterol (OR=1.25,
95%CI=1.14-1.39), and arthritis (OR=1.24, 95%CI=1.12-1.37) were all positively associated with CRC screening (p<0.05).
Females were less likely to screen for CRC than to males (OR=0.72; 95% CI=0.65-0.80). Compared to young adults (18-44
years), screening was significantly higher in middle-aged (45-64 years) and elder adults (65+) (OR=2.60, 95%CI=2.11-3.21 and
OR=2.67, 95%CI=2.13-3.33, respectively). African Americans were more likely to screen for CRC compared to their white
counterparts (OR=1.61, 95% CI=1.44-1.81).
Conclusions: We have found significant associations between chronic conditions and CRC screening uptake. We also found
higher uptake of CRC screen in African Americans than Whites, in contrast to earlier findings.

Keywords: Colorectal cancer; Screening; Cancer history; Hypertension; Cholesterol; Arthritis
Academic Editor: Xiaomin Zeng, MD, School of Biostatistics and Epidemiology, Central South University, China
Received: September 1, 2014; Accepted: November 2, 2014; Published: November 29, 2014
Competing Interests: The authors have declared that no competing interests exist.
Copyright: 2014 Wang KS et al. This is an open-access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited.
*

Correspondence to: Ke-Sheng Wang, Department of Biostatistics and Epidemiology, College of Public Health, East Tennessee

State University, PO Box 70259, Lamb Hall, Johnson City, TN 37614-1700, USA; Email: wangk@etsu.edu

Ivy Union Publishing | http: //www.ivyunion.org

November 29, 2014 | Volume 2 | Issue 1

Owusu D et al. American Journal of Cancer Epidemiology and Prevention 2014, 2:32-42

Page 2 of 11

Introduction
Colorectal cancer (CRC) is the fourth leading cause of cancer mortalities globally [1]. It accounted for
608, 000 deaths worldwide in 2008 [1]. CRC affects both sexes significantly. In the United States (US), CRC
is the third most common cancer and the second leading cause of cancer deaths; it was estimated that 136, 830
people would be diagnosed with CRC and about 50, 310 people would die of the disease in the US in 2014 [2].
The lifetime risk of CRC is about 5% for both men and women in the US [3, 4]. Five year survival rate of
CRC is low at late diagnosis of the disease; however, CRC death can be prevented by early detection and
treatment. Five-year survival rate has been shown to be at least 90% when the condition is detected early and
treated before tumor has extended; survival reduces to 70% when tumor has extended and is under 13% when
metastasis has already taken place [3, 5].
Deaths from CRC have been decreasing for both men and women in the US [6]. There has also been
declining rate of CRC incidence which is attributed to a reduction in exposure to risk factors, early detection,
and prevention by polypectomy [7]. Early detection, prevention, and early treatment are possible due to
availability of screening programs for at risk groups in the US. Uptake of screening therefore remains crucial
in the prevention of both the incidence of CRC and its mortality. Screening for CRC is effective, safe, and
relatively inexpensive [8]. A significant reduction in deaths from CRC attributed to screening has been shown
in both randomized trials and observational studies [9-12]. Different screening tools exist for CRC. Sensitivity
and specificity for various tests have been shown to be appropriate for screening [8]. For instance, a clinical
trial has shown that a single sigmoidoscopy screening of adults between 55 and 64 years resulted in 33% and
43% reductions in incidence and mortality of CRC, respectively [13]. In the US, a consensus guideline for
CRC screening has been published and screening is covered by most health plans [14].
However, uptake of CRC screening is still about 50% of those eligible or for whom the test is highly
recommended [2, 15]. Predictors of CRC screening are similar to those of other tests and they include age,
educational level, income level, being married, and health insurance status [15, 16]. But unlike other cancer
screening tests such as mammography, CRC screening rates remains low despite availability of effective and
safe test tools. In contrast to the well-known gender differences in health behavior [17], men show higher
acceptance rate for CRC screening than females [18,19]. Public health researchers have sought to find an
answer to this deviation. Some have asserted that the observation may be explained by the fact that the
incidence of colonic adenomas is higher in men than women [20], hence, the assumption that it is a male
condition [21]. Others also observed that over-emphasis on similar health conditions with screening guidelines
specific to women such as breast and cervical cancer seem to have focused women’s attention on those
conditions to the detriment of CRC screening [22,23]. However, since physician visits have been found to
correlate with CRC screening [21,24], it is expected that women screening for breast cancer and other diseases
will receive information on CRC risk and the need for screening. Such awareness will dispel any
misconception about CRC. On the other hand, if attention to other well publicized health programs hinders
CRC screening, it raises a question regarding the effect one health concern has on other important health
issues. Will attention to other chronic disease affect health behavior towards another important health issues?
Studies have so far not well evaluated the association between chronic diseases and CRC screening. A study to
find this association will not only answer an important question but will also inform policy about the need to
tailor CRC screening to other chronic disease management.

Methods
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Data source
The National Health Interview Survey (NHIS) is a multi-purpose health survey conducted by the National
Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), and is the principal
source of information on the health of the civilian non-institutionalized household population of the US. The
NHIS has been conducted continuously since 1957. Public use data files are released on an annual basis. From
each family in the NHIS, one sample adult aged 18 years or older is randomly selected, and information is
collected with sample adult core questionnaires. The 2012 NHIS sample size is the largest sample size since
the current sample design was implemented in 2006. Detailed methods of this survey have been published
elsewhere [25].

Variables
Subjects were considered to have had CRC screening if they responded “yes” to the question “During the past
12 months, have you had any test done for colon cancer?” (Table 1). Colon cancer tests include blood stool
tests, colonoscopy and sigmoidoscopy. A blood stool test is a test that may use a special kit at home to
determine whether the stool contains blood. A sigmoidoscopy and colonoscopy involve insertion of a tube into
the rectum to view the colon for signs of cancer or other health problems. Social factors used in this study
were age group classified as young (18-44 years), middle aged (45-64 years), and elderly (65 years or older),
gender, race/ethnicity (White, African American (AA), Asian and other). Other demographic characteristics
included education (≤high school, > high school) and health insurance (yes, no). Marital status had three
categories: married/living with partner, widowed/divorced/separated, and never married. All health condition
variables were dichotomized to yes or no. Cancer history was defined by the question “Ever been told by a
doctor you had cancer?” Arthritis was defined by the question “Ever been told by a doctor you had arthritis?”
Hypertension was asked by the question “Ever been told by a doctoryou had hypertension?” High cholesterol
was determined by the question “Ever been told by a doctor you had high cholesterol?” Ulcer was defined by
the question “Ever been told by a doctor you had an ulcer?”

Statistical Analysis
The SAS PROC SURVEYFREQ procedure was used to weight and estimate population proportions in
chronic conditions and social factors. SAS PROC SURVEYMEANS was used to estimate the overall
prevalence of CRC screening, whereas SAS PROC SURVEYFREQ determined the prevalence in potential
determinants. The Chi-square test was used to compare prevalence across chronic conditions. Then, SAS
PROC SURVEYLOGISTIC was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs)
for the relationship between potential factors and CRC screening. We estimated both crude and adjusted odds
ratios for our independent variables. Since colorectal cancer incidence increases with age, we set the young
adults as our reference for the analysis. All the analyses were conducted with SAS statistical software, version
9.2 (SAS Institute, Cary, NC, USA).
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Table 1 Subjects characteristics of the 2012 National Health Interview Survey

CRC screening (weighted %)

Non-screening (Weighted %)

N=4,040

N=17,471

Male

2026(54%)

7516(46%)

Female

2014(46%)

9955(54%)

18-44 years

182(5%)

2609(16%)

45-64 years

2194(59%)

9340(57%)

65 +

1664(36%)

5522(27%)

White

2819(79%)

13015(80%)

AA

800(13%)

2469(10%)

Asian

129(3%)

547(3%)

Other

292(5%)

1440(7%)

2205(70%)

8916(66%)

1447(24%)

6401(25%)

385(6%)

2105(9%)

≤HS

1776(42%)

8668(49%)

>HS

2210(58%)

8438(51%)

No

106(2%)

1597(7%)

Yes

3933(98%)

15857(93%)

No

3285(82%)

15406(88%)

Yes

753(18%)

2054(12%)

No

1833(48%)

9899(60%)

Yes

2203(52%)

7549(40%)

No

3574(89%)

16013(92%)

Yes

462(11%)

1444(8%)

No

2078(52%)

10976(63%)

Yes

1953(48%)

6432(37%)

No

2364(60%)

11822(69%)

Yes

1673(40%)

5629(31%)

Variable
Gender

Age group

Race

Marital status
Married
Widowed/Divorced/Separate
Never
Education

Insurance

Cancer history

Hypertension

Ulcer

High cholesterol

Arthritis

Abbreviations: AA=African American; HS=High school
*Data Source: CDC/NCHS, National Health Interview Survey, 2012
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Table 2 CRC screening prevalence in chronic disease conditions (%)

Variable

Total

(N)

CRC screening

(N)

Prevalence (%)

95%CI

P

<0.0001

Cancer history
No

18691

3285

17.6

16.9-18.3

Yes

2807

753

26.4

24.4-28.4

No

11732

1833

15.8

14.9-16.6

Yes

9752

2203

22.7

21.8-23.7

No

19587

3574

18.2

17.5-18.8

Yes

1906

462

25.0

22.6-27.3

No

10976

2078

15.9

15.1-16.7

Yes

8385

1953

23.3

22.2-24.4

No

14186

2364

16.5

15.8-17.3

Yes

7302

1673

23.4

22.1-24.6

21511

4040

18.8

18.1-19.4

Hypertension
<0.0001

Ulcer
<0.0001

High cholesterol
<0.0001

Arthritis

Overall

<0.0001

P-value is based on χ test
*Data Source: CDC/NCHS, National Health Interview Survey, 2012
2

Results
Subjects characteristics and prevalence
A total of 21,511 respondents, comprising 9,542 (44%) males and 11,966 (56%) females were included in the
analysis. Table 1 shows the characteristics of the study participants. In males, the percentage of CRC
screening was higher than the non-screening group (54% vs. 46%). Prevalence of CRC screening was higher
in older adults than young adults (36% vs. 27%). AA adults and married adults reported higher cases of CRC
screening than Whites and never married respectively (13% vs. 10%, 70% vs. 66%, respectively). More adults
with higher education and health insurance received CRC screening than low education and uninsured (58%
vs. 51%, 98% vs. 93%, respectively).

Table 2 shows the prevalence of CRC screening in chronic disease conditions. The overall prevalence of CRC
screening was 19%. The prevalence of CRC screening in adults with cancer history, hypertension, ulcer, high
cholesterol, and arthritis were significantly higher than those without the chronic conditions (26% vs.18%,
23% vs.16%, 25% vs.18%, 23% vs. 16%, and 23% vs. 17%, respectively).
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Table 3 Univariate and multiple logistic regression analyses for the relationship between potential factors and CRC
screening
Variable

Crude OR

95% CI

P-value

Adjusted OR

95% CI

P-value

0.65-0.80

<0.0001

Gender
Male

1

Female

0.75

1
0.68-0.82

<0.0001

0.72

Age group
18-44 years

1

45-64 years

2.98

2.42-3.68

<0.0001

2.60

1
2.11-3.21

<0.0001

65 +

3.76

3.03-4.66

<0.0001

2.67

2.13-3.33

<0.0001

Race
White

1

AA

1.39

1.24-1.54

<0.0001

1.61

1
1.44-1.81

<0.0001

Asian

0.99

0.78-1.26

0.760

1.10

0.86-1.40

0.450

Other

0.81

0.68-0.96

0.0032

1.04

0.87-1.24

0.663

Marital status
Married
Widowed/Divorced/Separate
Never

1

1

0.90

0.82-0.99

0.0304

0.87

0.79-0.96

0.0072

0.66

0.57-0.76

<0.0001

0.73

0.63-0.85

<0.0001

1.18-1.44

<0.0001

2.73-4.76

<0.0001

1.26-1.60

<0.0001

1.08-1.30

0.0003

1.10-1.48

0.0013

1.14-1.39

<0.0001

1.12-1.37

<0.0001

Education
≤HS

1

>HS

1.35

1
1.22-1.49

<0.0001

1.30

3.42-6.16

<0.0001

3.60

Insurance
No

1

Yes

4.59

1

Cancer
No

1

Yes

1.70

1
1.51-1.91

<0.0001

1.42

Hypertension
No

1

Yes

1.58

1
1.45-1.72

<0.0001

1.18

Ulcer
No

1

Yes

1.50

1
1.31-1.73

<0.0001

1.28

1.46-1.76

<0.0001

1.25

High cholesterol
No

1

Yes

1.60

1

Arthritis
No

1

Yes

1.55

1
1.41-1.70

<0.0001

1.24

Abbreviations: AA=African American; HS=High school; OR=Odds ratio; CI=Confidence interval
*Data Source: CDC/NCHS, National Health Interview Survey, 2012
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The relationship between all potential risk factors and CRC screening
Table 3 shows the results of both univariate and multiple regression analyses of the potential factors with
CRC screening. All factors were associated with CRC in the univariate analysis (p<0.05). After adjusting for
potential confounding factors, cancer history (OR=1.42, 95%CI=1.26-1.60), hypertension (OR=1.18,
95%CI=1.08-1.30), ulcer (OR=1.28, 95%CI=1.10-1.48), high cholesterol (OR=1.25, 95%CI=1.14-1.39), and
arthritis (OR=1.24, 95%CI=1.12-1.37) were all positively associated with CRC screening (p<0.05). Females
were less likely to screen for CRC than males (OR=0.72; 95% CI=0.65-0.80). Compared to young adults
(18-44 years), screening was significantly higher in middle-aged and elder adults (OR=2.60,
95%CI=2.11-3.21 and OR=2.67, 95%CI=2.13-3.33, respectively). AAs were more likely to screen for CRC
than white counterparts (OR=1.61, 95% CI=1.44-1.81). Compared to the married, screening uptake was less
likely in the divorced/widowed/separated (OR=0.87, 95% CI=0.79-0.96) and in the never married (OR=0.73,
95%CI=0.63-0.85). Education was significantly associated with CRC screening. Education level higher than
senior high school is associated with 30% increase in the odds of CRC screening. The odds of CRC screening
within the last 12 months in those who had insurance were 3.6 times that of those who did not have insurance
(95% CI=2.73-4.76).

Discussion
In this study, we found that the prevalence of CRC screening in adults with cancer history, hypertension, ulcer, high
cholesterol, and arthritis was significantly higher than those without those chronic conditions. After adjusting for
potential confounding factors, cancer history, hypertension, ulcer, high cholesterol, and arthritis were all positively
associated with CRC screening (p<0.05).
As has been reported earlier, CRC screening rate is lower in women than men. Adjusting for all potential
variables, CRC screening was still significantly higher in men than women. Some researchers have attributed
the low uptake of CRC screening in women to the perception that CRC is men’s disease [17]. Others have
proposed there is a greater attention to other cancers such as breast cancer and such attention has
overshadowed the importance of CRC [22,23]. However, since presence of other chronic diseases has been
found to increase uptake of CRC screening, the diverted attention hypothesis does not fully explain the
gender difference in CRC screening. Again, since physician visit has been found to increase CRC screening
[17,18], awareness of the conditions seems to be very important in the decision to screen.
We also found screening uptake to increase with age. More than 90% of all those who reported having been
screened for CRC were over 44 years old. Screening uptake was highest in those above 64 years. The age
difference is explained by the fact that CRC risk increases with age and screening is recommended for those
who 50 years [26] and above in the US.
In terms of race, CRC screening uptake was significantly higher in AA compared to Whites while all other
races were not significantly different from Whites. This finding contrasts earlier observations [15,16]. The
higher uptake rate in AAs may be due to the fact that both incidence of and mortality from CRC are highest in
AAs [27-31] than all other ethnic groups in the US.
Our results indicate that being married or living with a partner increases the chance of being screened for
CRC. Those who are divorced, separated or widowed were also better off in uptake of CRC screening than
Ivy Union Publishing | http: //www.ivyunion.org
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the never-married group. It has been known that being married is associated with CRC screening uptake [16].
An earlier study attributed the health difference to financial protection enjoyed by unemployed married
women [32]. However, Schoenborn (2004) observed that married adults were healthier than other adults
regardless of population demographics or health indicator [33]. The difference in screening uptake, aside from
other factors, may be due to support couples enjoy from their partners. However, a longitudinal study may be
able to better explain this difference.
Level of education was also found to determine the likelihood of CRC screening uptake in our sample.
Those who have received education higher than senior high school are more likely to receive screening for
CRC. Education is well known to be a significant determinant of health. In terms of screening, education level
of an individual may influence the level of understanding of CRC and the benefits of screening. Such insight
is more likely to drive a person to accept and undergo screening [34].
Insurance significantly increases the chances of being screened for CRC in our sample. Odds of been
screened for CRC in the past 12 months in those insured were 3.6 times that of those who did not have any
insurance. It has been shown that most insurance policies currently cover CRC screening [26]. Such coverage
offers a relief of further financial burden from a CRC screening, and therefore lead to increased uptake of
CRC screening by those insured. On the other hand, the uninsured may be constrained financially to screen
for CRC. Again, differences in insurance status may reflect differences in economic level in our sample.
Effect of insurance status on CRC screening may also be explained by health consciousness. With the same
socio-economic levels, people who are more health conscious are more likely to buy health plans than those
who are less health conscious. The difference in attitude toward health is more likely to result in significant
differences in screening uptake. Another possible explanation for the effect of insurance status is risk
perception. People who perceive themselves as being at increased risk for health problems are more likely to
buy health plans and offer themselves for screening than those who perceive themselves as not being at risk
for health problems.
All of the chronic conditions included in the analysis were significantly associated with CRC screening
uptake in both the univariate and multiple logistic regression analyses. Among the chronic conditions, cancer
history showed the strongest association with CRC screening uptake. People diagnosed with cancer may
consider themselves at risk of other cancers and therefore will take advantage of existing screening programs.
Being treated for a cancer will likely expose an individual to the awareness of CRC screening and the benefit
associated with it. It has been shown that family CRC history is a predictor for CRC screening [35]. History
of having an ulcer was second to cancer in terms of strength of association with CRC screening. Investigation,
treatment and education to ulcer patients are more likely to lead acceptance and uptake of CRC screening.
Of greater interest is the effect of elevated cholesterol level on CRC screening uptake. It showed the third
strongest strength of association with screening uptake. Since elevated cholesterol level is asymptomatic and
more unlikely to lead people to seek medical attention, its association with CRC screening is more likely
mediated by health consciousness. Furthermore, it has been reported that individuals who have high
cholesterol do seem to have an increased risk of CRC [36].
High blood pressure and arthritis also showed an association with CRC screening uptake. Like the other
chronic conditions, hypertension and arthritis are more likely to bring patients into contacts with physicians
and other health professionals more often. Such contacts may lead to awareness of available health services
including CRC screening and increase in the uptake of screening. People coming into contact more often with
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physicians are more likely to receive information on CRC screening, resulting in an increase in uptake [21,24].
Few studies have focused on the relationship between arthritis and hypertension and CRC screening. One
recent study reported that individuals with rheumatoid arthritis (RA) did not appear to be at risk for receiving
fewer cancer screening tests than non-RA patients; while there was no significant difference in having at least
one Pap smear, mammogram or colonoscopy between patients with RA and hypertension [37].

Strengths and limitations
Our study used a nationally representative sample and therefore the results can be generalized. The large
sample size also gives us a statistical power in our estimates. However, since the study is a cross-sectional,
causal association cannot be established. Further, our analysis is based on self-report and therefore prone to
recall bias. However, colon cancer test is relatively invasive and it is unlikely that an individual will not recall
this diagnosis.

Conclusion
We have found significant association between chronic conditions and CRC screening uptake. In contrast to
earlier findings, we have found higher uptake of CRC screen in AA than Whites. Further studies should
examine whether this association is mediated by physician visits. It is important to develop effective strategies
to manage these chronic conditions; the role of physicians in the CRC screening should be stressed.
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